Literature DB >> 15714219

Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.

Judith C T van Deutekom1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15714219     DOI： 10.1038/sj.ejhg.5201381

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  5 in total

Review 1.  The function of dog models in developing gene therapy strategies for human health.

Authors:  Keri L Nowend; Alison N Starr-Moss; Keith E Murphy
Journal:  Mamm Genome       Date:  2011-07-06       Impact factor: 2.957

2.  Hybrid spectrin type repeats produced by exon-skipping in dystrophin.

Authors:  Nick Menhart
Journal:  Biochim Biophys Acta       Date:  2006-04-19

3.  Injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study.

Authors:  Niels Hilhorst; Ifigenia Spanoudi-Kitrimi; Nathalie Goemans; Marie-Anne Morren
Journal:  Eur J Pediatr       Date:  2018-11-17       Impact factor: 3.183

Review 4.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04

5.  Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides.

Authors:  Shashank R Sirsi; Rebecca C Schray; Margaret A Wheatley; Gordon J Lutz
Journal:  J Nanobiotechnology       Date:  2009-04-07       Impact factor: 10.435
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.